Kathleen Borthwick
Vermögen: 31 170 $ am 31.05.2026
Vermögen: 31 170 $ am 31.05.2026
Kathleen Borthwick is currently Chief Financial Officer at Passage Bio, Inc. since 2024.
Formerly, Ms. Borthwick was Head-Business Development at Johnson & Johnson Services, Inc. Education includes an MBA from Tuck School of Business at Dartmouth and an undergraduate degree from The Wharton School of the University of Pennsylvania.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PASSAGE BIO, INC. 0.17% | 16.03.2026 | 5’402 ( 0.17% ) | 31 170 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| PASSAGE BIO, INC. | Finanzdirektor/CFO | 28.07.2023 |
| Unternehmen | Position | Ende |
|---|---|---|
Johnson & Johnson Services, Inc.
Johnson & Johnson Services, Inc. Pharmaceuticals: OtherHealth Technology Operates as medicine and health care products manufacturing company | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Johnson & Johnson Services, Inc.
Johnson & Johnson Services, Inc. Pharmaceuticals: OtherHealth Technology Operates as medicine and health care products manufacturing company | Health Technology |
Tuck School of Business at Dartmouth
Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Passage Bio, Inc.
Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen